Information Sharing in Collaborative Drug Therapy Management Service by Doctors, Medical Technologists and Pharmacists for Prevention of Hepatitis B Virus Reactivation Caused by Cancer Chemotherapy-Reference-Cited by-同舟云学术

Information Sharing in Collaborative Drug Therapy Management Service by Doctors, Medical Technologists and Pharmacists for Prevention of Hepatitis B Virus Reactivation Caused by Cancer Chemotherapy

Published:2015 Issue:10 Volume:41 Page:677-686
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Uchihata Kumiko¹,Osaki Seiichi¹,Takahashi Kyouhei¹,Murakami Teruaki¹,Hanamoto Kozue²,Ishida Katsunari²,Miyashita Manabi³,Kuyama Shoichi⁴,Yoshida Akimasa⁵,Nigota Motofumi⁶

Affiliation:

1. Department of Pharmacy, National Hospital Organization Iwakuni Clinical Center

2. Department of Clinical Laboratory, National Hospital Organization Iwakuni Clinical Center

3. Department of Hepatology, National Hospital Organization Iwakuni Clinical Center

4. Department of Respiratory Medicine, National Hospital Organization Iwakuni Clinical Center

5. Department of Pharmacy, National Hospital Organization Okayama Medical Center

6. Department of Pharmacy, National Hospital Organization Shikoku Cancer Center

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_677/_pdf

Reference3 articles.

1. Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Diseases Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepatitis

2. 7) Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, Leung N, Luk JM, Lie AK, Kwong YL, Liang R, Lau GK, Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy, Gastroenterology, 2006, 131, 59-68.

3. 8) Kusumoto S, Tanaka Y, Ueda R, Mizokami M, Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy, Journal of Gastroenterology, 2010, 46, 9-16.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of Protocol-Based Pharmacotherapy Management (PBPM) Using an Electronic Medical Record Interlocking Support System to Prevent Hepatitis B Virus Reactivation Induced by Cancer Chemotherapy;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2022-01-10

2. Pharmacist Orderings for Blood and Urine Tests Related to Pharmaceuticals;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2021-07-10

3. Improving Adherence to the Guideline on Hepatitis B Virus Reactivation;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2020-03-10

4. New role of Japanese pharmacists focusing on medication therapy management in a team care approach;Journal of Pharmacy Practice and Research;2020-01-30

5. Safe Selection of Sleeping Medications for Patients with Acute Stroke Who Were Chronic Users of Benzodiazepine/Non-Benzodiazepine;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2019-04-10